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; MBoC | BOOK REVIEW and this book is most assuredly not that. A third possibility would have been a more global recitation of the history of cell biology (written either by a member of the guild with that perspective or a historian of science). Such a book would have included all the tributaries, not just one key center. And this book is not that either. The
The French surgeon-biologist Alexis Carrel joined the Rockefeller Institute for Medical Research in 1906, five years after the Institute had been founded and coincident with the opening of its first permanent building on the former Schermerhorn farm. (Carrel would go on to win a Nobel Prize in 1912, but he later was tainted by having been a regent in the French Vichy government.) As the century opened, in a suite of labs at Rockefeller that perpetually smelled of aerosolized carbolic acid (aka phenol, the standard antibacterial agent used at the time), Carrel worked out ways to keep pieces of tissue alive. Such work had been underway elsewhere, most ably by Ross Harrison at Johns Hopkins and later by Thomas Strangeways and Honor Fell in Great Britain. But Carrel got much more attention, in both the professional and public media, when he reported that he had kept a culture of cardiac tissue rhythmically contracting for more than 20 years. Moberg does a masterful job of describing the next "tissue culture" era, led by James Murphy, whose arrival at Rockefeller in 1910 may have been the tipping point for the nascent science called cell biology that would unfold aside the East River in Manhattan.
I have known more than one scientist who worked with Murphy and have always been puzzled about how, as they moved into the modern era, they nonetheless described their flasks and bottles of single cells as "tissue cultures" as opposed to "cell cultures," the term I grew up with later as a postdoc in Harry Eagle's cell biology department at the Albert Einstein College of Medicine. One time I asked one of these senior figures to explain-Paul Zamecnik (Pederson, 2011) , who had worked in another lab at Rockefeller but had met Murphy and learned tissue culture from him. I can only paraphrase what he said but have always remembered his key point. It went something like, "Thoru, in those ancient days we had a piece of tissue in a fibrin clot. But at the edges single cells would proudly march out. There, in that borderland, tissue culture became single cell culture. But in our papers and parlance, we felt we should describe the entire landscape in the dish or chamber-hence I still use the term tissue culture." Point accepted of course, and so charmingly expressed, as was Zamecnik's style.
In what might not have been so well appreciated, this tissue to cell culture "borderland" may well have been a key step in Rockefeller's rise to prominence in cell biology, as Moberg engagingly tells us. It needed only one new player. The curtain opens, and we all know who walks on stage: Keith Roberts Porter.
Most of us who knew Keith-it seems unbelievable that he has been gone 16 years-regarded him as the pioneer of electron microscopy that he was. But he was first and foremost a biologist, more specifically a histologist, and it was his zeal to look at cells and tissues at greater and greater magnification that egged him on. The chapters on Murphy's tissue culture program, Porter's arrival and research, the role of the Rockefeller's famed machine shop, the collaboration with Josef Blum to devise the first microtome that could cut sections thin enough for electron microscopy-all this Moberg presents in erudite detail as has never been done before. When the Radio Corporation of America had an electron beam-based instrument ready for testing, Porter took no chances. Instead of a thin section, he grew some fibroblasts (shades of Murphy) on a plastic film and put the whole preparation under the beam, supported by a wire mesh. The result was one of the most iconic micrographs in the history of cell biology, in which every organelle and membrane system hitherto suspected was vividly manifest. In a deft touch as to both the image and its history, Moberg wisely put this electron micrograph on her book's cover.
author states up front that her perch was and is Rockefeller. This focal plane is a great story in and of itself. So then, what are the structural/style deficiencies to which I referred? They simply derive from the fact that Moberg could not possibly have done it alone-I'm not sure any living cell biologist could. So what we have is a book in which the author has written richly evocative chapters (more on them to follow) and has also been an über-organizer/editor in commissioning other chapters from the best people (with perhaps one or two exceptions). But the result is predictably uneven, as some of the commissioned chapters delve less into historical dimensions than Moberg so ably does in those of her own. To say it differently, some of the chapters written by others read like standard review articles. There are also some imbalances here and there-for example, the work of David Luck is very lightly covered, as is that of key people affiliated with him, including Bernie Gilula and Bessie Huang. The important plant cell biology pioneer Nam-Hai Chua is hardly mentioned, nor is a pioneer of cell microinjection, Elaine Diacumakos . Some but not all of these omissions may be grounded in the author's tendency to cover the heads of labs, an understandable approach, given the European style of Rockefeller's organization that prevailed until the 1990s. Finally, to finish my "summary of gripes," it could be said that although the author does state that her focus is Rockefeller, there might have been a little more attention to at least other Manhattan centers of confluence. Here are two examples. At Columbia, Franz Schrader, Sally HughesSchrader, and Arthur Pollister were onto DNA long before anyone was serious about it at Rockefeller (except for the solitary Oswald Avery). It would not have diminished the book for this to have been mentioned. The first DNA work at Rockefeller, post-Avery, was done by a visiting scientist, Hans Ris, in a lab headed by Alfred Mirsky but largely done when Mirsky was away on his honeymoon. Uptown at Columbia, similar studies were being done in Arthur Pollister's lab by a student, Hewson Swift. The import of these two independent studies (based on Feulgen cytophotometry) was nothing less than the concept of DNA constancy, a major heuristic step in the modern era of cell biology and genetics (Pederson, 2005) . Moberg could have brought forth a few such stories, at least in the Manhattan setting that is her quarter in the book.
Moberg's decision to keep her story within the Rockefeller campus, which is understandable, does have its consequences as to history. For example, there was a major controversy with a Harvard Medical School group on issues of vascular permeability and glomerular, and the reality/nonreality of gap junctions. But I think getting into this and various other rivalries with extramural camps would not have been well placed here.
Finally, I found the coverage of research on the nucleus and chromatin at Rockefeller to be very weak. Sadly, this chapter needed to be completed after Vincent Allfrey died, in 2012. Vince was someone I knew well, and it is a shame he couldn't have finished this chapter. Alas, it is full of errors, including an uninterpretable, vacuous electron micrograph (Figure 1, p. 399 ) and an insultingly inaccurate priority claim on the discovery of nucleosomes (op. cit. and p. 409, where Figure 3 is erroneously described). Also seriously missing from this chapter is a deserved account of how Rachelle Maggio, Philip Siekevitz, and George Palade isolated what was at the time the highest purity of liver nuclei and derived from them nucleoli and nucleoplamsic fractions that represented as clean a separation as has been made to this day from any cell or tissue (Maggio et al., 1963a,b) .
OK-that's all of my negatives, and they are neutralized, well beyond the pH dye shift, by the many positives, which are the following.
The other major epistemological axis in the chapters Moberg wrote is cell fractionation. She describes in engaging detail how centrifuges of higher and higher force generation were imported, modified, or built at Rockefeller and how these machines put the York Avenue crowd ahead of almost all others in the game. Reading these superb chapters, I got to thinking: when our students do a 11,000 × g spin for 3 min in a microfuge or an overnight run at 10-fold or more greater forces, do they have any idea where these principles and machines came from? Sadly, they have little interest, but for those who do, Moberg tells the whole story, at least from her admitted sole Rockefeller angle. The other locus was Uppsala and Theodor Svedberg, but her account of the Rockefeller chapter leaves no doubt as to its gravitas (pun intended).
Cell fractionation takes us to an epochal event in cell biology at Rockefeller, the arrival of the Belgian Albert Claude in 1929. He brought a style of cell science that integrated pathology, histology, microscopy, and cell fractionation that had not crystallized as such a promising congression of expertise for the future of cell science anywhere else at the time. Claude and, in my opinion, Keith Porter, were clearly the heterogeneous catalysts that led to everything else that so magnificently unfolded to empower the Rockefeller campus into the pantheon of cell biology. Moberg has gotten this all so right, and this sector of her book alone is worth much more than the purchase price.
I close on Moberg's favorite Rockefeller character, in whose lab she worked for many years, and who was a favorite cell biologist of mine-Phil Siekevitz. The concept of "biochemical cytology" was personified and enabled by the embryologist Jean Brachet and Albert Claude, both Belgians. This concept meant getting one's hands on cell fractions. Most people think of Siekevitz as the wonderful cell biologist that he was, but in formal terms he was a biochemist, trained by David Greenberg at Berkeley, Paul Zamecnik at Massachusetts General Hospital, and Van Potter at Wisconsin, arguably three of the most forward-looking biochemists at the time. There can be no doubt that Siekevitz's arrival at Rockefeller mightily boosted the group Claude was assembling, the other stars of which were of course George Palade and Claude's fellow Belgian Christian de Duve (also a biochemist). Carol Moberg's career with Siekevitz gave her the inside track, and she comes across in the book as a grateful witness to history and a scholar of the Rockefeller era in the advent of cell biology. She has engagingly told the vibrant story that unfolded there, and we owe her an enormous debt for having done so.
